Pattern of lymph node metastasis in thoracic esophageal squamous cell carcinoma with poor differentiation

Zhang,Jinling; Liu,Yuanyuan; Che,Fengyuan; Luo,Yi; Huang,Wei; Heng,Xueyuan; Li,Baosheng

doi:10.3892/mco.2018.1606

Pattern of lymph node metastasis in thoracic esophageal squamous cell carcinoma with poor differentiation

Authors:
- Jinling Zhang
- Yuanyuan Liu
- Fengyuan Che
- Yi Luo
- Wei Huang
- Xueyuan Heng
- Baosheng Li
View Affiliations

Affiliations: Cancer Center, Linyi People's Hospital Affiliated to Shandong University, Linyi, Shandong 276000, P.R. China, Cancer Center and Steering Committee, Linyi People's Hospital Affiliated to Shandong University, Linyi, Shandong 276000, P.R. China, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48105, USA, Department of Radiation Oncology (Chest Section), Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital, Shandong Academy of Medical Sciences, Shandong University, Jinan, Shandong 250117, P.R. China
Published online on: April 13, 2018 https://doi.org/10.3892/mco.2018.1606
Pages: 760-766

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to explore the pattern of lymph node metastasis (LNM) in poorly‑differentiated esophageal squamous cell carcinoma (pdESCC) and the implication of postoperative irradiation. A total of 690 patients with pdESCC were retrospectively investigated. The rates of intro‑thoracic and extra‑thoracic LNM in pdESCC were investigated and compared to previous research on ESCC en bloc. The comparison of the rates between pdESCC and ESCC were performed using the Cochran‑Mantel‑Haenszel test. The clinicopathological factors associated with LNM in pdESCC were analyzed by Chi‑squared tests, and Fisher's exact test was used to assess the rate difference of extra‑thoracic LNM. Logistic‑regression analysis was used to explore risk factors associated with lymph node (LN) station. Results demonstrated that the distribution pattern of LNM in pdESCC was significantly different compared with that of ESCC (P<0.05). Univariate and multivariate analysis indicated that risk factors associated with LNM were depth and length (P<0.001 and P<0.001) and multivariate analysis also indicated that the location of the tumor (P=0.042) was a risk factor associated with LNM in pdESCC. Metastasis in the abdominal cavity was significantly higher than in the neck in the middle and lower thoracic pdESCC (both P<0.01). LN station 102 and 7 for upper thoracic ESCC, 101 and 105 for middle thoracic ESCC, and 100 for lower thoracic ESCC were identified as high‑risk stations for metastases in pdESCC compared to ESCC. Several parameters, including location and neck metastasis, were identified as risk factors of metastasis for the above sites, respectively. In conclusion, postoperative therapy should include more LN stations in pdESCC depending on risk factors of tumor metastasis individually.

View Figures

View References

1	Esophageal Disease Society Research: Preface, general principles, part IPatrick Barron J: Guidelines for clinical and pathologic studies on carcinoma of the esophagus. 9. Tokyo: Kanehara: pp. 72–73. 2004
2	Liu J, Liu Q, Wang Y, Xia Z and Zhao G: Nodal skip metastasis is associated with a relatively poor prognosis in thoracic esophageal squamous cell carcinoma. Eur J Surg Oncol. 42:1202–1205. 2016. View Article : Google Scholar : PubMed/NCBI
3	Du D, Song T, Liang X, Fang M and Wu S: Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: A systemic review and pooled analysis of the literature. Dis Esophagus. 23:1–9. 2016.
4	Japan Esophageal Society, . Japanese classification of esophageal cancer, 11th edition. Esophagus. 14:37–65. 2017. View Article : Google Scholar : PubMed/NCBI
5	Kim KH, Chang JS, Cha JH, Lee IJ, Kim DJ, Cho BC, Park KR and Lee CG: Optimal adjuvant treatment for curatively resected thoracic esophageal squamous cell carcinoma: A radiotherapy perspective. Cancer Res Treat. 49:168–177. 2017. View Article : Google Scholar : PubMed/NCBI
6	Cheng J, Kong L, Huang W, Li B, Li H, Wang Z, Zhang J, Zhou T and Sun H: Explore the radiotherapeutic clinical target volume delineation for thoracic esophageal squamous cell carcinoma from the pattern of lymphatic metastases. J Thorac Oncol. 8:359–365. 2013. View Article : Google Scholar : PubMed/NCBI
7	Li J, Wang L, Wang X, Zhao Y, Liu D, Chen C, Zhang HP and Pan J: Preliminary study of the internal margin of the gross tumor volume in thoracic esophageal cancer. Cancer Radiother. 16:595–600. 2012. View Article : Google Scholar : PubMed/NCBI
8	Yamasaki M, Miyata H, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and Doki Y: Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: Proposed modifications for improved survival stratification: Impact of lymph node metastases on overall survival after esophagectomy. Ann Surg Oncol. 21:2850–2856. 2014. View Article : Google Scholar : PubMed/NCBI
9	Li B, Chen H, Xiang J and Zhang Y, Li C, Hu H and Zhang Y: Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience. J Thorac Cardiovasc Surg. 144:778–786. 2012. View Article : Google Scholar : PubMed/NCBI
10	Tanaka K, Yano M, Motoori M, Doki Y, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, et al: The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer. Dis Esophagus. 25:146–152. 2012. View Article : Google Scholar : PubMed/NCBI
11	Chen H, Wu Z, Chen J, Lin X, Zheng C, Fan Y, Zhang Z, Yao X, Wu J, Xu L, et al: Postoperative adjuvant therapy for resectable thoracic esophageal squamous cell carcinoma: A retrospective analysis of 426 cases. Med Oncol. 32:4172015. View Article : Google Scholar : PubMed/NCBI
12	Li M, Zhang X, Liao Z, Meng X, Kong L, Zhang X, Shi F, Zhang Y, Wei G, Man H, et al: Failure patterns after definitive chemoradiation therapy with involved-field irradiation for locally advanced esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 90:12. 2014. View Article : Google Scholar
13	Wang S, Wang Z, Yang Z, Liu Y, Liu X, Shang B and Jiang WP: Postoperative radiotherapy improves survival in stage pT2N0M0 esophageal squamous cell carcinoma with high risk of poor prognosis. Ann Surg Oncol. 23:265–272. 2016. View Article : Google Scholar : PubMed/NCBI
14	Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z and Liu X: Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol. 95:229–233. 2010. View Article : Google Scholar : PubMed/NCBI
15	Deslauriers J: Preface. Thoracic anatomy: Pleura and pleural spaces, mediastinum, diaphragm, and esophagus. Thorac Surg Clin. 21:xiii–xiv. 2011. View Article : Google Scholar : PubMed/NCBI
16	Shinoda M, Ando N, Kato K, Ishikura S, Kato H, Tsubosa Y, Minashi K, Okabe H, Kimura Y, Kawano T, et al: Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303). Cancer Sci. 106:407–412. 2015. View Article : Google Scholar : PubMed/NCBI
17	Chen J, Liu S, Pan J, Zheng X, Zhu K, Zhu J, Xiao J and Ying M: The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Surg Oncol. 36:480–486. 2009.
18	Matsuda S, Tsubosa Y, Niihara M, Sato H, Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yasui H, Takeuchi H, et al: Distribution of lymph node metastasis and clinical validity of gastric tube reconstruction in lower thoracic esophageal squamous cell carcinoma with gastric invasion. Ann Surg Oncol. 22:617–623. 2015. View Article : Google Scholar : PubMed/NCBI
19	Ren X, Zhao Z, Huang W, Liu H, Dong C and Li Y: Analysis of the characteristics and factors influencing lymph node metastasis in thoracic esophageal carcinoma and cancer of the gastric cardia. Hepatogastroenterology. 62:73–76. 2015.PubMed/NCBI
20	Van der Schaaf M, Johar A, Wijnhoven B, Lagergren P and Lagergren J: Extent of lymph node removal during esophageal cancer surgery and survival. J Natl Cancer Inst. 107:pii: djv043. 2015.PubMed/NCBI
21	Yokota T, Igaki H, Kato K, Tsubosa Y, Mizusawa J, Katayama H, Nakamura K, Fukuda H and Kitagawa Y: Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial. Int J Clin Oncol. 21:283–288. 2016. View Article : Google Scholar : PubMed/NCBI
22	Jain S and Dhingra S: Pathology of esophageal cancer and Barrett's esophagus. Ann Cardiothorac Surg. 6:99–109. 2017. View Article : Google Scholar : PubMed/NCBI
23	Juloori A, Tucker SL, Komaki R, Liao Z, Correa AM, Swisher SG, Hofstetter WL and Lin SH: Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy. J Thorac Oncol. 9:534–540. 2014. View Article : Google Scholar : PubMed/NCBI
24	Cavallin F, Alfieri R, Scarpa M, Cagol M, Ruol A, Fassan M, Rugge M, Ancona E and Castoro C: Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: A cohort study. BMC Surg. 17:492017. View Article : Google Scholar : PubMed/NCBI